Safety, Tolerability, PK and PD of ADX-038 in Healthy Participants and Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients
Clinical trial NCT05876312 · RECRUITING
Trial details
- NCT number
- NCT05876312
- Sponsor
- ADARx Pharmaceuticals, Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-07
- Primary completion
- 2028-03-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.